Back to top
more

Molina Healthcare (MOH)

(Real Time Quote from BATS)

$188.82 USD

188.82
915,659

-1.89 (-0.99%)

Updated Sep 25, 2025 02:48 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 5% (234 out of 246)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Anthem (ANTM) Gears Up for Q3 Earnings: What's in Store?

by Zacks Equity Research

Anthem (ANTM) is likely to have gained from solid revenues in the third quarter.

Zacks Equity Research

Nokia (NOK) to Report Q3 Earnings: What's in the Offing?

by Zacks Equity Research

Solid progress in its expansion areas of Software and Enterprise and excellent momentum in IP Routing business are likely to have benefited Nokia's (NOK) third-quarter 2019 financial results.

Zacks Equity Research

Molina Healthcare Sees Hammer Chart Pattern: Time to Buy?

by Zacks Equity Research

Molina Healthcare has been struggling lately, but the selling pressure may be coming to an end soon.

Zacks Equity Research

What's in the Cards for Centene's (CNC) Earnings in Q3?

by Zacks Equity Research

Centene's (CNC) third-quarter earnings are likely to have grown on the back of solid revenues.

Zacks Equity Research

UnitedHealth Group (UNH) in Focus: Stock Moves 8.2% Higher

by Zacks Equity Research

UnitedHealth Group (UNH) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

Zacks Equity Research

Why Molina (MOH) is Poised to Beat Earnings Estimates Again

by Zacks Equity Research

Molina (MOH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Equity Research

Is Molina Healthcare (MOH) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Is (MOH) Outperforming Other Medical Stocks This Year?

Sapna Bagaria headshot

UnitedHealth (UNH) Q3 Earnings and Revenues Beat, Guidance Up

by Sapna Bagaria

UnitedHealth's (UNH) higher revenues, strength in both segments -- UnitedHealthcare and Optum -- plus membership growth leads to earnings outperformance.

Zacks Equity Research

Humana to Provide Florida's Retirees With Medicare Plans

by Zacks Equity Research

Humana's (HUM) Medicare plans to help the State of Florida Medicare-eligible retirees and their eligible dependents achieve better health outcomes.

Zacks Equity Research

MEDNAX (MD) to Sell MedData for Focusing on Core Business

by Zacks Equity Research

MEDNAX (MD) to divest its billing services business for streamlining its operations.

Zacks Equity Research

Is Molina (MOH) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Will UnitedHealth's (UNH) Benefits Business Aid Q3 Earnings?

by Zacks Equity Research

Strength in UnitedHealth's (UNH) health service segment is likely to reflect in Q3 results.

Zacks Equity Research

The Zacks Analyst Blog Highlights: KB Home, Beazer, American Electric and Molina

by Zacks Equity Research

The Zacks Analyst Blog Highlights: KB Home, Beazer, American Electric and Molina

Zacks Equity Research

Humana's New Plans to Complement VA Healthcare Coverage

by Zacks Equity Research

Humana's (HUM) Humana Honor Medicare Advantage plans to help veterans get better health outcomes. It will also complement the VA plan.

Tirthankar Chakraborty headshot

4 Stocks to Win Big as Powell Hints at Another Rate Cut

by Tirthankar Chakraborty

Fed Chair Powell leaves the door open for another rate cut in October as jobs growth last month was not as robust as expected and trade concerns continue to impede economic growth.

Zacks Equity Research

Centene's Carolina Complete Health Wins Medicaid Contract

by Zacks Equity Research

Centene's (CNC) provider-led North Carolina subsidiary clinches Medicaid contract to provide services in additional areas.

Zacks Equity Research

Humana's (HUM) Medicare Business Aids, High Costs Persist

by Zacks Equity Research

Humana's (HUM) revenues and membership gain on strong Medicare business. However, high expenses hurt.

Tirthankar Chakraborty headshot

Economic Worries Buoy Rate-Cut Hopes: 5 Winners

by Tirthankar Chakraborty

Worries about a probable economic downturn have increased this week, fueling rate-cut hopes. CME's Fedwatch indicator showed that almost 90.3% of investors are now expecting another rate cut.

Zacks Equity Research

Tenet Healthcare's Strategic Initiatives Aid, Revenues Drag

by Zacks Equity Research

Strategic divestitures bode well for Tenet Healthcare's (THC) growth. However, depleting revenues is a lingering woe.

Zacks Equity Research

Molina (MOH) Stock Moves -0.22%: What You Should Know

by Zacks Equity Research

In the latest trading session, Molina (MOH) closed at $109.48, marking a -0.22% move from the previous day.

Zacks Equity Research

Universal Health (UHS) Up 27.6% YTD: Will the Rally Continue?

by Zacks Equity Research

Universal Health (UHS) is poised to grow over the long term on the back of strong contribution from its segments and accretive acquisitions.

Zacks Equity Research

Molina Healthcare Enters Oversold Territory

by Zacks Equity Research

Molina Healthcare, Inc. (MOH) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.

Zacks Equity Research

Are Investors Undervaluing Molina (MOH) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Molina Healthcare Sees Hammer Chart Pattern: Time to Buy?

by Zacks Equity Research

Molina Healthcare has been struggling lately, but the selling pressure may be coming to an end soon.

Zacks Equity Research

UnitedHealth to Offer New Medicare Advantage Plan in Bay Area (Revised)

by Zacks Equity Research

UnitedHealth's (UNH) new Medicare Advantage Plan to serve Medicare beneficiaries in Bay Area.